Medications for Opioid Use Disorder (MOUD)
2 AMA PRA Category 1 Credits ™
This 4-hour introductory course discusses medications for opioid use disorders (MOUD). The course includes a video recorded in June 2023 and resources from SAMHSA hosted in PDF format for ease of downloading or printing.
Harry L. Haus, MD, JD, MBA, medical director of Harry Haus MD & Associates. Dr. Haus has been practicing MAT (now called MOUD) since 2007. He is board certified in addiction medicine and family medicine.
Julie Kmiec, DO, is an assistant professor of psychiatric, University of Pittsburgh School of Medicine. Dr. Kmiec specializes in psychiatry and is certified in addiction psychiatry and psychiatry by the American Board of Psychiatry and Neurology.
This video will:
- Discuss the pharmacology of buprenorphine
- Discuss regulatory changes in how buprenorphine can be prescribed
- Describe buprenorphine preparations, dosing, and adverse reactions
- Describe appropriate monitoring/body fluid toxicology testing
The Pennsylvania Medical Society (PAMED) is accredited by the Accreditation Council on Continuing Medical Education (ACCME) to provide continuing medical education for physicians. PAMED designates this enduring material for a maximum of 4 AMA PRA Category 1 credits™. Physicians should claim credit commensurate with their participation in the activity. No one involved in the planning or delivery of this activity has any relevant financial relationships to disclose.
Enduring material posted: Nov. 15, 2023
Enduring material expires: Dec. 31, 2026